Ramsay Générale de Santé SA (EPA:GDS)
France · Delayed Price · Currency is EUR 9.18
-0.10 (-1.08%)
At close: Jan 9, 2026
Ramsay Générale de Santé Market Cap
Ramsay Générale de Santé has a market cap or net worth of €1.01 billion as of January 9, 2026. Its market cap has decreased by -25.97% in one year.
Market Cap
1.01B
Enterprise Value
4.74B
Revenue
5.24B
Ranking
n/a
PE Ratio
n/a
Stock Price
€9.18
Market Cap Chart
Since June 15, 2001, Ramsay Générale de Santé's market cap has increased from 259.00K to 1.01B, an increase of 391,093.43%. That is a compound annual growth rate of 40.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 1.01B | -1.08% |
| Dec 31, 2025 | 1.02B | -25.16% |
| Dec 31, 2024 | 1.37B | -34.74% |
| Dec 29, 2023 | 2.10B | 3.83% |
| Dec 30, 2022 | 2.02B | -14.48% |
| Dec 31, 2021 | 2.36B | 19.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 100.86B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |